Month: May 2022

With 22.2% CAGR, Next-Generation Sequencing Market Size worth USD 31411.3 million by 2026

Written by Customer Service on May 5, 2022. Posted in Mergers And Acquisitions.

According to Fortune Business Insights, the global Next-Generation Sequencing Market size is projected to reach USD 31,411.3 million in 2026, at CAGR of 22.2% during forecast period; Diversified Applications of Next-Generation Sequencing in Diagnostics, are Driving the Market Pune, India, May 05, 2022 (GLOBE NEWSWIRE) — The global Next-Generation Sequencing Market size is expected to gain momentum by reaching USD 31,411.3 million by 2026 while exhibiting a CAGR of 22.2% between 2019 to 2026. In its report titled “Next Generation Sequencing Market, 2019-2026.”, Fortune Business Insight mentions that the market stood at USD 6,335.2 million in 2018. The rising demand for cost-effective and accurate DNA sequencing to treat genetic diseases is expected to drive the market. Moreover, the launch of several genomic projects in countries...

With 10.6% CAGR, Prefilled Syringes Market Size worth USD 15.20 Billion by 2029

Written by Customer Service on May 5, 2022. Posted in Mergers And Acquisitions.

According to Fortune Business Insights, the global Prefilled Syringes Market size is projected to reach USD 15.20 Billion in 2029, at CAGR of 10.6% during forecast period; Heavy Demand for Biologics to Contribute Growth Pune, India, May 05, 2022 (GLOBE NEWSWIRE) — The global prefilled syringes market size was USD 15.20 Billion in 2029 while exhibiting a CAGR of 10.6% between 2021 and 2029. This information is provided by Fortune Business Insights™, in its report, titled, “Prefilled Syringes Market, 2021-2029.” The report further mentions that the market stood at USD 6.60 billion in 2021. According to our researchers, the growing occurrence of prolonged diseases, such as diabetes and other autoimmune illnesses is expected to fuel the market demand during the mentioned period. For example, as per the American Autoimmune Related Diseases...

With 19.9% CAGR, Global Video Streaming Market Size Worth USD 1,690.35 Billion in 2029

Written by Customer Service on May 5, 2022. Posted in Mergers And Acquisitions.

According to Fortune Business Insights, the global Video Streaming Market Size is projected to reach USD 1,690.35 billion in 2029, at CAGR of 19.9% during forecast period; Growing Demand for VoD to Enhance Demand for Service Pune, India, May 05, 2022 (GLOBE NEWSWIRE) — The global video streaming market size was valued at USD 372.07 billion in 2021. The market is projected to grow from USD 473.39 billion in 2022 to USD 1,690.35 billion by 2029, exhibiting a CAGR of 19.9% during the forecast period. This information is provided by Fortune Business Insights, in its report titled, “Video Streaming Market Share, 2022-2029.” Key Industry Development: January 2022: IBM Corporation declared an innovative IBM streaming mobile application that globally refines the communications happening in workplace. The mobile application is made accessible...

With 11.1% CAGR, Cryptocurrency Market Size Worth USD 1902.5 Million in 2028

Written by Customer Service on May 5, 2022. Posted in Mergers And Acquisitions.

According to Fortune Business Insights, the global cryptocurrency market size is projected to reach USD 1902.5 million in 2028, at a CAGR of 11.1% during forecast period; Growing Adoption of Digital Currencies to Augment Market Growth Pune, India, May 05, 2022 (GLOBE NEWSWIRE) — The global cryptocurrency market size is likely to reach USD 1902.5 million by 2028, exhibiting a CAGR of 11.1% during the forecast period. In its report titled “Cryptocurrency Market Size, Share and Growth”, Fortune Business Insight mentions that the market stood at USD 826.6 million in 2020. Cryptocurrency is a system of virtual currency exchange that is aimed to eliminate financial intermediaries. It offers low ownership costs, quicker and safer transactions internationally through a decentralized record storing platform called ‘distributed ledger’....

Vital Farms Reports First Quarter 2022 Financial Results

Written by Customer Service on May 5, 2022. Posted in Earnings Releases And Operating Results.

First Quarter Net Revenue exceeds $77 million, up over 31% versus Prior Year Maintains Fiscal Year 2022 Outlook AUSTIN, Texas, May 05, 2022 (GLOBE NEWSWIRE) — Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today reported financial results for its first quarter ended March 27, 2022. Financial highlights for the first quarter include:First Quarter 2022 Net Revenue increase of 31.6% to $77.1 million First Quarter 2022 Net Loss of $1.5 million First Quarter 2022 Adjusted EBITDA of $0.5 million1“This year is off to the strong start we projected,” said Russell Diez-Canseco, Vital Farms’ President and Chief Executive Officer. “Vital Farms is the fastest-growing brand in dollars in the egg category.2 We’re delivering on our growth plans with continued gains in retail...

With 23.2% CAGR, Mobile Advertising Market Size Worth USD 621.63 Billion in 2029

Written by Customer Service on May 5, 2022. Posted in Mergers And Acquisitions.

According to Fortune Business Insights, the global mobile advertising market size is projected to reach USD 621.63 billion in 2029, at CAGR of 23.2% during forecast period; Rapid Adoption of Mobile Campaigns to Propel Market Progress Pune, India, May 05, 2022 (GLOBE NEWSWIRE) — The global mobile advertising market size was valued at USD 117.97 billion in 2021 and is expected to reach USD 144.08 billion in 2022. The market is expected to reach USD 621.63 billion by 2029, exhibiting a CAGR of 23.2% during the forecast period. Rapid adoption of mobile campaigns and the integration of VR & AR with mobile advertising platform are expected to enhance industry progress. Fortune Business Insights™ provides this information in its report titled “Mobile Advertising Market, 2022-2029.” Key Industry Development May 2021: Mobvista completed...

Intercept Announces Advanz Pharma to Acquire Ocaliva in PBC in Markets Outside the U.S. for up to $450MM, including $405MM Upfront and an Additional $45MM in Contingent Payments

Written by Customer Service on May 5, 2022. Posted in Mergers And Acquisitions.

Agreement includes rights for Advanz to commercialize orphan drug Ocaliva® for PBC outside the U.S., as well as the transition to Advanz of the international commercial and medical infrastructure of Intercept Additionally, Intercept will receive royalties on any future ex-U.S. net sales of obeticholic acid in NASH Intercept to discuss further details during Q1 2022 earnings call on Friday, May 6th at 8:30 a.m. ET MORRISTOWN, N.J., May 05, 2022 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced it has entered into an agreement to sell to Advanz Pharma, a pharmaceutical company with a strategic focus on specialty and hospital pharmaceuticals in Europe, certain...

CoreCard Corporation Reports First Quarter 2022 Results

Written by Customer Service on May 5, 2022. Posted in Earnings Releases And Operating Results.

NORCROSS, Ga., May 05, 2022 (GLOBE NEWSWIRE) — CoreCard Corporation [NYSE: CCRD], the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, announced today its financial results for the quarter ended March 31, 2022. “CoreCard’s strong performance continued in the first quarter and resulted in total net revenue of $24.3 million which actually exceeded the high end of our expectations,” said Leland Strange, CEO of CoreCard Corporation. “Our significant top-line growth was driven by $12.5 million in license revenue, combined with 14% growth in professional services revenue and processing and maintenance revenue growth of 56%. We continue to invest in our platform and processing capabilities, which are showing encouraging results. We also continue...

HII Reports First Quarter 2022 Results

Written by Customer Service on May 5, 2022. Posted in Earnings Releases And Operating Results.

Revenues were $2.6 billion in the quarter Net earnings of $140 million, $3.50 diluted earnings per share Delivered Virginia-class submarine Montana (SSN 794) Delivered amphibious transport dock Fort Lauderdale (LPD 28) Company reaffirms FY22 revenue, margin and free cash flow1 guidanceNEWPORT NEWS, Va., May 05, 2022 (GLOBE NEWSWIRE) — HII (NYSE:HII) reported first quarter 2022 revenues of $2.6 billion, up 13.1% from the first quarter of 2021, primarily driven by revenue attributable to the acquisition of Alion Science and Technology (Alion) in the third quarter of 2021. Operating income in the first quarter of 2022 was $138 million and operating margin was 5.4%, compared to $147 million and 6.5%, respectively, in the first quarter of 2021. The decreases in operating income and operating margin were primarily driven by lower...

Zentalis Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update

Written by Customer Service on May 5, 2022. Posted in Earnings Releases And Operating Results.

Announced initial data on ZN-c3 in combination with chemotherapy in advanced ovarian cancer and interim data on ZN-c3 in uterine serous carcinoma (USC) at AACR Received a $25 million equity investment from Pfizer, with plans to jointly advance clinical development of ZN-c3, and expanded its Scientific Advisory Board with the addition of Pfizer’s Dr. Adam Schayowitz Initiated a potentially registrational Phase 1/2 study of ZN-d5 in patients with relapsed or refractory light chain (AL) amyloidosis Cash runway extended into Q1 2024, with Pfizer’s equity investment and budget reallocation NEW YORK and SAN DIEGO, May 05, 2022 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways...

Month: May 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals